ZURICH, Dec 28 (Reuters) - The following are some of the main factors expected to affect Swiss stocks on Thursday: COMPANY STATEMENTS * Novartis: Luye Pharma Group Ltd. said a German court of appeal dismissed an appeal from Novartis AG in a patent infringement lawsuit regarding Rivastigmine 1 day patch to treat Alzheimer’s disease. * Syngenta said it intends to voluntarily delist its American Depositary Shares from the New York Stock Exchange and subsequently deregister and terminate its U.S. reporting obligations. ECONOMY
Novartis is a Swiss company.
It doesn't say whether Novartis is Swiss or not.
( z1 company :mod ( z2 country :name ( z3 name :op "Switzerland" ) ) :domain ( z4 company :name ( z5 name :op "Novartis" ) ) )